Golden Eye-Grass (Sisyrinchium californicum and Related Sisyrinchium Species)
1. Identity, Taxonomy, and Botanical Description
1.1 Primary Species and Common Names
The plant most specifically known as "golden-eyed grass" is Sisyrinchium californicum, a species of flowering plant in the iris family known by the common names golden blue-eyed grass, yellow-eyed-grass, and golden-eyed-grass. It is native to the west coast of North America from British Columbia to central California, where it grows in moist habitat, often in coastal areas.
The common name "golden eye-grass" can also refer loosely to several other yellow-flowered members of the genus Sisyrinchium. Two species from Arizona resemble S. californicum, both called Yellow-eyed or Golden-eyed Grass: S. cernuum, found in southeastern Arizona and Mexico, has petal-like segments less than 1/4 of an inch (6 mm) long, with flowers on slender bent stalks; S. longipes, found from northern Arizona to Mexico, has petal-like segments 3/8β1/2 of an inch (8β13 mm) long, with flowers on erect stalks. Elmer's Golden-eyed Grass (S. elmeri), which has stems generally less than 1/8 of an inch (2 mm) wide, is found in much of California. Arizona Golden-eyed Grass (S. arizonicum) is a robust plant with branched stems bearing yellow-orange flowers more than one inch (2.5 cm) wide; it grows in the mountains of eastern Arizona and western New Mexico.
In the ethnobotanical and herbal literature, the medicinally referenced "golden eye-grass" is most consistently identified with S. californicum, though traditional uses documented for the broader genus β particularly Sisyrinchium angustifolium Mill. (narrow-leaf blue-eyed grass) β are frequently cited in the same context. Sisyrinchium californicum, called golden-eyed grass, is noted for its yellow flowers, but most species of Sisyrinchium produce blue flowers; although their foliage is grass-like, the plants in the genus Sisyrinchium belong to the iris family, not the grass family.
1.2 Taxonomy and Classification
Sisyrinchium is a large genus of annual to perennial flowering plants in the family Iridaceae. Native to the New World, the species are known as blue-eyed grasses. Although they are not true grasses (Poaceae), they are monocots.
The genus was named by Carl Linnaeus in 1753, based on the species Sisyrinchium bermudiana (commonly called Bermudiana). The taxonomy of this genus is rather perplexing and confusing, as several of these species, such as Sisyrinchium angustifolium, form complexes with many variants named as species; more genetic research and cladistic analysis need to be performed to sort out the relationships between the species.
The taxonomy of the group is quite confused, so the number of species varies from 50 to 150, depending on which classification system is used; some species have many natural variants that were likely mis-named as species β so more research is needed to figure out the true relationships.
The accepted botanical authority for Sisyrinchium californicum is Sisyrinchium californicum (Ker Gawl.) W.T. Aiton. Synonyms in the literature include Hydastylus borealis, Hydastylus brachypus, Hydastylus californicus, and Sisyrinchium boreale.
1.3 Morphological Description
Sisyrinchium californicum is a rhizomatous perennial herb producing a pale green, nonwaxy stem which grows up to about 60 centimeters tall. The foliage turns dark brown or black as it dries. The flat, narrow leaves are grasslike. The flower has six tepals each between 1 and 2 centimeters in length; they are light to bright yellow, often with brown veining. The fruit is a dark-colored capsule.
This is a clump-forming plant that produces a tuft of narrow grass-like leaves typically rising to 8β12 inches tall. Yellow star-like flowers, each with 6 pointed tepals, bloom atop naked flowering stems that are distinctly flattened and winged. Heaviest bloom is in MayβJune, with lesser continued bloom often occurring into the summer. Flowers close up by noon each day.
The closely related S. angustifolium is similarly described: Sisyrinchium angustifolium, commonly known as narrow-leaf blue-eyed-grass, is a herbaceous perennial growing from rhizomes, native to the eastern United States, stretching as far west as Texas and Kansas, where it is the most common blue-eyed grass. It is commonly cultivated as an ornamental. Height: 15β50 cm (6β20 in). Stem: broadly winged, 2β4 mm (1/16β3/16 in) wide, usually branched. Leaves: 2β6 mm (1/16β1/4 in) wide. Tepals: 6, blue, 7β10 mm (1/4β3/8 in), each tipped with a sharp point, veined, and darkening toward central yellow patch.
1.4 Native Habitat and Range
Sisyrinchium californicum is primarily native to moist-wet peripheries of ponds, bogs, marshes, lakeshores, moist grasslands, and other moist sites along the Pacific coast from California north to southern British Columbia.
S. angustifolium is found throughout the eastern US, as far north as Newfoundland and Quebec, and as far west as Texas. Its native habitat consists of meadows, damp fields, open woods, moist pinelands, swamp edges, and grassy roadsides.
1.5 Common Preparations and Forms
Historically, golden eye-grass and its congeners have been used in the following forms, as documented in ethnobotanical sources:
- Root tea (decoction/infusion): Native Americans used the roots to make a tea to treat worms and stomach aches. The plant was also used as a laxative to treat diarrhea in children.
- Whole-plant tea (infusion): An infusion of the root is used to treat diarrhoea in adults and children. The leaves are eaten as a cooked green to regulate the bowels. An infusion of the plant has been used to treat stomach complaints and stomach worms.
- Cooked leaves (edible preparation): The leaves were cooked and eaten by Native Americans as a medicinal plant and were said to regulate the bowels.
No standardized commercial supplement forms (capsules, standardized extracts, tinctures, or powders) are described in the peer-reviewed or institutional literature reviewed. The plant is primarily encountered as a wildcraft botanical used in traditional preparations rather than a formulated dietary supplement.
2. Traditional and Historical Use
2.1 Native American Ethnobotany
Sisyrinchium species have a long history of medicinal use. They are an Appalachian folk medicine for fever and chills, and the plants were used by Native American tribes to treat ailments including hayfever, diarrhea, and stomach ache.
Most Sisyrinchium are considered laxatives and have been used by different tribes in North America to treat digestive problems (Austin 2004).
The University of Florida IFAS Extension, drawing on Austin's 2004 Florida Ethnobotany, documents that Native Americans used the roots to make a tea to treat worms and stomach aches, and the plant was used as a laxative to treat diarrhea in children as well.
For S. angustifolium specifically, the USDA-associated Lady Bird Johnson Wildflower Center database records: Amerindians used root tea for diarrhea (in children); plant tea for worms and stomachaches. Several species were used as laxatives.
The Iroquois tradition specifically documented use of the related Sisyrinchium montanum (Mountain Blue-eyed Grass): The Iroquois used it as a drug β specifically as a cathartic for old people β as documented by Herrick in his 1977 PhD thesis on Iroquois Medical Botany at the State University of New York.
2.2 Appalachian Folk Medicine
The book Edible & Medicinal Wild Plants of Minnesota & Wisconsin notes that Sisyrinchium species have a long history of medicinal use. They are an Appalachian folk medicine for fever and chills, and were used by Native American tribes for a wide variety of ailments.
2.3 Culinary Use
Several ethnobotanical sources also document limited culinary use. Leaves were cooked and mixed with other greens. The leaves of Sisyrinchium angustifolium were traditionally cooked and consumed by Native American women for their potential benefits in regulating bowel movements and promoting digestive health.
2.4 Broader Iridaceae Family Medicinal Context
The Iridaceae family, to which golden eye-grass belongs, has a broad traditional medicinal footprint. Plants belonging to this family have been used in traditional medicine for the treatment of different ailments including cold, flu, malaria, toothache, bruises, and burns. Notably, the related family genus Iris has an extensive pharmacological and historical record: the peeled and dried rhizomes of Iris Γ germanica, Iris florentina, and Iris pallida, known collectively as Rhizoma iridis, were valued for their emetic, cathartic, stimulant, expectorant, and errhine properties and were also used in tooth powders. While this context illuminates the broader medicinal tradition within the iris family, it cannot be directly extrapolated to Sisyrinchium without species-specific evidence.
3. Phytochemistry: Key Constituents and Chemical Classes
No comprehensive published phytochemical analysis specifically of Sisyrinchium californicum has been identified in the peer-reviewed literature searched. The phytochemical profile of the genus must be inferred from the broader Iridaceae family literature and from limited genus-level reports. The following summarizes what is verifiable from authoritative sources.
3.1 Astringent Compounds (Tannins)
The root of Sisyrinchium angustifolium is astringent. Astringency in botanical medicines is typically attributed to tannins (condensed or hydrolysable polyphenols). Tannins are secondary metabolites that, when present in plant roots, mechanistically account for antidiarrheal effects through protein precipitation at mucosal surfaces and reduction of intestinal secretion. This is consistent with the ethnobotanical use of root infusions for diarrhea.
3.2 Phenolic Compounds and Flavonoids
The Iridaceae family to which Sisyrinchium belongs is known for producing a range of phenolic metabolites. Research on the closely related genus Gynandriris (formerly included in or closely allied to Sisyrinchium by some classifications) has yielded specific phytochemical data: Chemical investigation of Gynandriris sisyrinchium (L.) Parl. growing in Jordan resulted in the isolation and characterization of a total of twelve compounds, two of which are reported for the first time in nature. These new compounds included the isoflavones 3'-methyl tenuifone and gynandrinone. In addition, ten known compounds including Ξ²-sitosterol, 7,3'-dimethoxy-5,6,4'-trihydroxyisoflavone, iristectorigenin, hispidulin, galangustin, 6-hydroxybiochanin A, ursolic acid, ladanetin, 4'-O-methylgenistein, and Ξ²-sitosterol glucoside are also reported from G. sisyrinchium.
The broader Iris genus, the closest well-studied relative, is characterized by: rhizomes that are a rich source of secondary metabolites belonging to the classes of flavonoids, isoflavonoids, xanthones, stilbenes, simple phenolic compounds, triterpenoids, quinones, and irons; these phytochemicals contribute to the diverse and beneficial properties of Iris extracts.
It is important to note that the isoflavone and flavonoid profile of Gynandriris sisyrinchium cannot be directly attributed to Sisyrinchium californicum or S. angustifolium without independent analytical studies of those specific taxa.
3.3 Limitations of Current Phytochemical Knowledge
No peer-reviewed, species-specific chromatographic or spectroscopic analysis (e.g., HPLC, GC-MS, NMR) of Sisyrinchium californicum's phytochemical composition has been identified in the available literature. The chemical constituents of this species remain incompletely characterized in the published scientific record. Claims about specific active compounds in golden eye-grass therefore rest on inference from related Iridaceae taxa rather than direct analytical evidence.
4. Proposed Mechanisms of Action
Because no direct mechanistic studies on Sisyrinchium californicum extracts have been identified in the peer-reviewed literature, proposed mechanisms are inferred from the plant's reported ethnobotanical uses, its astringent chemical properties, and from the broader pharmacological literature on its compound classes:
4.1 Gastrointestinal (Astringent/Antidiarrheal Mechanism)
The documented astringency of the root β the property most consistently reported across ethnobotanical sources β is attributable to tannins and related polyphenols. Astringent compounds act on gastrointestinal mucosa by precipitating surface proteins, reducing mucosal permeability, and diminishing secretory activity. This mechanism is broadly consistent with the traditional use of root infusions for diarrhea and gastrointestinal complaints. The root is astringent, and an infusion is used to treat diarrhoea in adults and children.
4.2 Cathartic/Laxative Mechanism
Several Sisyrinchium species are described as laxatives in the ethnobotanical record. Most Sisyrinchium are considered laxatives and have been used by different tribes in North America to treat digestive problems. Anthraquinone glycosides are a common mechanism behind botanical laxatives, but no direct identification of such compounds in Sisyrinchium has been confirmed in the sources reviewed.
4.3 Antipyretic Use (Fever and Chills)
Appalachian folk medicine use for fever and chills is documented but the mechanism has not been investigated scientifically in the Sisyrinchium genus. Anti-inflammatory properties of flavonoids and phenolic acids β compound classes present in related Iridaceae β are frequently cited as mechanistic explanations for antipyretic activity of medicinal plants in this family, but this connection has not been validated specifically for golden eye-grass.
5. Scientific Evidence by Area of Use
Note on evidentiary status: A systematic search of the peer-reviewed literature (including PubMed/PMC) has not identified any published human clinical trials, randomized controlled trials, observational studies, or animal pharmacological studies specifically using Sisyrinchium californicum or directed at characterizing the medicinal activity of "golden eye-grass" as a defined entity. The sections below characterize the evidence as it actually exists β which is limited to ethnobotanical documentation and extrapolation from related taxa.
5.1 Gastrointestinal Uses (Antidiarrheal, Laxative, Anthelmintic)
Traditional evidence: The most consistently documented use across multiple independent ethnobotanical sources is for gastrointestinal complaints. Amerindians used root tea for diarrhea (in children), and plant tea for worms and stomachaches; several species were used as laxatives. This is corroborated by the University of Florida IFAS Extension: most Sisyrinchium are considered laxatives and have been used by different tribes in North America to treat digestive problems.
Scientific evidence: No controlled human trials or animal pharmacological studies have been published specifically investigating the antidiarrheal, laxative, or anthelmintic activity of any Sisyrinchium species extract. The plausibility of antidiarrheal activity is supported by the documented astringency of the root, a chemical property consistent with antidiarrheal mechanisms. Evidence strength for this use is: traditional use only; no clinical or experimental data identified.
5.2 Antipyretic Use (Fever and Chills)
Traditional evidence: Sisyrinchium species have been used as Appalachian folk medicine for fever and chills.
Scientific evidence: No in vitro, animal, or clinical studies on fever reduction by Sisyrinchium extracts have been identified. Evidence strength: traditional/folk documentation only.
5.3 Hayfever / Allergic Rhinitis
Traditional evidence: The plants were used by Native American tribes to treat ailments including hayfever.
Scientific evidence: No scientific studies on this use have been identified. Evidence strength: single ethnobotanical reference; no supporting scientific data.
5.4 Broader Iridaceae Pharmacological Context
The broader family context is informative but cannot substitute for species-specific evidence. Plant extracts from Iris species possess anti-inflammatory, antioxidant, phytoestrogenic, antidiabetic, hepatoprotective, hypolipidemic, immunomodulating, antimutagenic, antimicrobial, antitumor, cytotoxic, antidepressant, anticholinesterase, and molluscicidal effects. Plants belonging to the Iridaceae family have been used in traditional medicine for the treatment of different ailments including cold, flu, malaria, toothache, bruises, and burns.
Research on Gynandriris sisyrinchium β a related Iridaceae species β found that isolated isoflavones displayed antioxidant and cytotoxic activities in laboratory assays. The antioxidant and cytotoxic activities of isoflavones from Gynandriris sisyrinchium were investigated. These findings are preliminary in vitro results from a different (though botanically allied) species, and cannot be extrapolated to predict clinical effects of golden eye-grass.
6. Body Systems Associated with Traditional Use
- Gastrointestinal system: The primary system addressed in documented traditional use. An infusion is used to treat diarrhoea in adults and children; the leaves are eaten as a cooked green to regulate the bowels; and an infusion of the plant has been used to treat stomach complaints and stomach worms.
- Immune/febrile response: Used as Appalachian folk medicine for fever and chills.
- Respiratory/allergic system: Used by Native American tribes for hayfever.
7. Dosage Forms and Reported Dosages
No standardized dosage recommendations appear in pharmacopeial monographs, official regulatory publications (NIH ODS, NCCIH, EMA, ESCOP, German Commission E), or peer-reviewed clinical studies for Sisyrinchium californicum or any other golden eye-grass species. The plant has not been the subject of formal dose-finding studies.
Ethnobotanical records describe the following preparation modes without specifying quantities, concentrations, or frequencies:
- Root infusion (tea): Prepared from the roots and administered orally for diarrhea and gastrointestinal complaints. Amerindians used root tea for diarrhea in children. No standardized dose was recorded in the historical literature.
- Whole-plant infusion: An infusion of the plant has been used to treat stomach complaints and stomach worms. No concentration or volume was specified in the sources reviewed.
- Cooked leaves consumed as food: The leaves were cooked and mixed with other greens. Quantity and frequency were not recorded in ethnobotanical documentation.
No information on clinically studied doses, extract standardization parameters, or daily intake thresholds for golden eye-grass has been identified in any authoritative source. Any dose figures found in commercial contexts are unsupported by the published scientific record.
8. Safety Considerations
8.1 Risk of Misidentification
The most clearly documented safety concern in authoritative botanical sources is the risk of misidentification. Field-collected plants should never be consumed, as many species have similar appearances but could be extremely toxic and deadly. The grass-like appearance of Sisyrinchium makes it superficially similar to a number of toxic monocots in moist habitats.
8.2 Absence of Formal Toxicological Data
No formal toxicological studies (acute toxicity, subchronic toxicity, genotoxicity, reproductive toxicity) have been published for Sisyrinchium californicum or S. angustifolium in the peer-reviewed literature. The safety profile of these species is therefore essentially uncharacterized by modern toxicological standards.
8.3 Family-Level Considerations
Within the Iridaceae family, phytochemical complexity is significant. The rhizomes of Iris species are a rich source of secondary metabolites belonging to the classes of flavonoids, isoflavonoids, xanthones, stilbenes, simple phenolic compounds, triterpenoids, and quinones. Some members of the Iridaceae produce compounds with emetic or cathartic activities β for example, the peeled and dried rhizomes of Iris Γ germanica, Iris florentina, and Iris pallida were valued for their emetic, cathartic, stimulant, and expectorant properties. Whether analogous compounds with emetic potential are present in Sisyrinchium species has not been investigated.
8.4 General Secondary Metabolite Toxicity
Globally, 10% of all vascular flora is utilized for medicinal purposes, and many of which contain some secondary metabolites that are toxic to animals including humans. Some toxic secondary metabolites fall into the categories of alkaloids, phenolics, terpenoids, tannins, saponins, cyanogen, and amino acids. The presence or absence of such compounds in golden eye-grass has not been characterized in the published scientific record.
8.5 Absence from Major Regulatory Databases
Sisyrinchium californicum and Sisyrinchium angustifolium are not listed as subjects of any monograph by the European Medicines Agency (EMA), the European Scientific Cooperative on Phytotherapy (ESCOP), the World Health Organization (WHO) herbal monograph series, the German Commission E, or the United States Pharmacopeia (USP). They are also not addressed in NIH Office of Dietary Supplements fact sheets or NCCIH herb summaries. This absence from major regulatory and pharmacopeial systems means that no official guidance on safe use, contraindications, or drug interactions exists.
8.6 Theoretical Drug Interactions
No drug interaction data specific to golden eye-grass has been published. Given the plant's postulated tannin content and the general pharmacological properties of tannins (protein precipitation, potential reduction of drug absorption), caution regarding co-administration with orally taken pharmaceuticals may be warranted in principle, but no specific interaction studies exist to confirm or characterize this risk.
9. Summary of Evidence Quality
The entirety of the documented medicinal evidence for golden eye-grass (Sisyrinchium californicum and closely related species) rests on ethnobotanical records and folk medicine traditions. While the plant's health benefits are not extensively researched, its historical use as a gentle medicinal herb indicates potential in areas such as digestion and inflammation. No randomized controlled trials, non-randomized clinical studies, animal pharmacological studies, or systematic reviews addressing the medicinal use of any Sisyrinchium species as a defined intervention have been identified in the peer-reviewed literature. The phytochemical composition of S. californicum specifically has not been published in peer-reviewed analytical studies. Evidence across all reported uses is therefore rated as: preliminary ethnobotanical documentation; no controlled experimental or clinical evidence.
References
Go back